This is the rat sequence of nesfatin-1, and it is the variant most of the foundational literature actually used. The peptide's identification as an anorexigenic factor acting independently of the leptin receptor came from rat studies, and the central administration protocols, dose ranges and feeding paradigms that later work builds on were established in that species. That has a direct practical consequence: a laboratory reproducing or extending published nesfatin-1 feeding experiments will usually find the methods transfer most cleanly with the rat peptide, whereas translating them to another species means re-establishing dose and route rather than adopting them. Rat work also supports the broader physiology, including the finding that NUCB2/nesfatin-1 production in stomach and adipose tissue varies with age, testosterone level and lactating status, which is the kind of baseline variability that determines how animals should be grouped. More recent work has moved past intake alone to ask what the peptide changes about eating behaviour, reporting that nesfatin-1 decreases the motivational and rewarding value of food. That distinction is worth designing for: operant or progressive-ratio paradigms will detect a shift in food valuation that simple consumption measurement can miss, and the two readouts can dissociate. | 